Loading...
Before 1985, transfusions of blood products to patients with hemophilia sometimes resulted in infection with HIV or hepatitis C virus (HCV). Whereas many deaths occurred from HIV infections prior to development of effective therapy, the consequences of HCV infections have been more subtle. Many HCV-infected patients have shown no evident disease; in others, liver damage has progressed gradually to end-stage liver disease (ESLD). Now, some 35 years after the first hemophilic patients became infected by HCV-containing blood products, an international consortium of hemophilia physicians describes the long-term outcomes of HCV infection.
The study cohort consisted of 847 patients whose median age at first HCV exposure was 14 (range, <1–77); medi…